Navigation Links
Phreesia Announces Clinical Initiative to Better Manage Symptoms of Parkinson's Disease
Date:4/15/2008

Effort utilizes Phreesia's automated patient check-in system to enable

better management of medication wear-off

NEW YORK, April 15 /PRNewswire/ -- Phreesia, Inc., the Patient Check-In Company, has announced that it will integrate a new screening tool developed by researchers at Duke University Medical Center into its electronic patient intake process, thereby potentially enhancing the ability of doctors to identify and manage the debilitating symptoms of Parkinson's disease.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080220/NYW106LOGO )

Affecting about one million people in the United States, Parkinson's disease is a degenerative disorder that impairs nerve cells causing patients to experience tremors, slowness of movement, muscle rigidity, and difficulty with balance. Drug therapy is highly effective, but within 2 years of initiating treatment up to 50% of patients can experience a decrease in drug efficacy, a phenomenon that is referred to as "wearing-off".

"Recognition of wearing-off and under treatment in Parkinson's disease patients is a major problem", said Mark Stacy, MD, Director of the Movement Disorders Center at Duke University's School of Medicine. Research has shown that nearly half of all patients that report wearing-off are not identified in a routine clinical exam. To help address this inconsistency, Phreesia will automate the "Wearing-Off Questionnaire-9" (WOQ-9), a highly sensitive screening tool specifically designed by researchers at Duke to identify these symptoms in the clinical setting.

Frequently, paper screening tools are cumbersome to implement clinically. As part of Phreesia's electronic patient intake system patients with Parkinson's disease will answer questions from the WOQ-9 and the results will be made available to their physician prior to starting the clinical exam. By enabling physicians
'/>"/>

SOURCE Phreesia, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
2. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
3. Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540
4. Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine
5. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
6. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
7. Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy
8. Perrigo Announces Approval for Over-the-Counter Childrens Cetirizine Oral Solution
9. Nuvelo Announces Preclinical Data for NU206 Demonstrating Potent Therapeutic Activity in Oral Mucositis Models
10. Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea
11. Antipodean Pharmaceuticals Announces Completion of Phase 2 Study of Lead Compound MitoQ(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 4, 2015   Mallinckrodt plc (NYSE: ... present at the Barclays Global Healthcare Conference at the ... , on Wednesday, March 11, 2015. Mark Trudeau, President and ... in a session scheduled to begin at 10:45 a.m. ... in person can find webcast information on Mallinckrodt,s ...
(Date:3/4/2015)...  ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ) announced ... Conference at the Ritz-Carlton at Laguna Niguel, California ... Arthur S. Przybyl , President and CEO, will give ... of ANI,s website at www.anipharmaceuticals.com . Mr. Przybyl,s presentation ... and available through the link through June 7, 2015. ...
(Date:3/3/2015)... JACKSONVILLE, Fla. , March 3, 2015 /PRNewswire/ ... is pleased to announce the hiring of ... Sales to lead business development efforts and build ... years of experience in software development, sales, and ... of enterprise software applications. iTraycer is a comprehensive ...
Breaking Medicine Technology:Mallinckrodt to Present at Barclays Conference March 11 2ANI Pharmaceuticals To Present At 27th Annual ROTH Conference 2Medical Tracking Solutions, Inc. Hires New SVP, Sales 2
(Date:3/4/2015)... 2015 The New Mel Brooks Musical ... will be performed by the award-winning Drama Department of ... March 6-22, 2015, on Fridays, Saturdays and Sundays. Performances ... School (27118 Silver Spur Road, Rolling Hills Estates, ... program or may be purchased on-line at https://sites.google.com/site/penhidrama ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Columbus is no ... steady prevalence of cocaine addiction, and suffers from the ... on Feb. 27th, the DEA revealed that Kratom is ... a herbal tea; the newly introduced herb from Southeast Asia ... in heightened doses. WKYC notes kratom foments symptoms similar to ...
(Date:3/4/2015)... 2015 The Alliance for Regenerative ... its upcoming fifth annual Advanced Therapies Summit next ... event this year will feature five expert-led interactive ... the field’s leading companies and organizations. , ... and clinical researchers from the advanced therapies community ...
(Date:3/4/2015)... Today Visiopharm announces that Patrik Dahlén, previously ... Visiopharm Board of Directors as Chairman. ... are positioned to become the fastest growing software company, ... research. , "Over the last several years, ... of ONCOtopix™ Dx, a complete quantitative digital pathology solution ...
(Date:3/4/2015)... Follow us on LinkedIn – ... increasing incidence of CNS disorders, aging population, rising healthcare ... The unmet medical needs for diagnosing and treating CNS ... market. Presently, there exists an urgent need for developing ... current generation drugs. Companies are therefore investing to develop ...
Breaking Medicine News(10 mins):Health News:The New Mel Brooks Musical Young Frankenstein Performance March 6-March 22, 2015, by the Award Winning Drama Department at Peninsula High School, Rolling Hills 2Health News:Columbus, OH Combats the Sale of Kratom as a Drug, Harbor Village Detox Stresses Caution 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 3Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 2Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 3Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 4
... Patients with a specific kind of lung cancer may benefit ... UCSD Cancer Center. The new drug, crizotinib, under development by ... some patients during Phase I and II clinical trials. ... encouraging," said Lyudmila Bazhenova, MD, assistant clinical professor at UC ...
... ... RE/MAX agent who participates in the “Home for the Cure™” program, through ... for the Cure when a home sale is complete. The newly rebranded ... signs, is meant to raise money for breast cancer research, education and ...
... St. Gregory Retreat ... Health Program. , ... 22, 2010 -- St Gregory Centers, Inc. announced today that they have signed agreements with ... employees. The Mayo Clinic program will be an integral part of St Gregory’s Life ...
... to be published on 21 June 2010 in the ... (Inserm unit 625 Research Group on Human and ... Hospital Centre) in Pointe Pitre (urology department, University ... the Center for Analytical Research and Technology (University of ...
... Researchers at the Oregon Health & Science University ... bioluminescence a way of measuring visible light generated from ... rapidly assessing in children at the chair-side the number of ... to tooth decay. The study is published ...
... ... to young women. They promote thinness at all costs and often disregard ... Journal of Public Health published a recent study of Pro Ana websites. This ... Stanford University School of Medicine, has raised questions about how we can meet ...
Cached Medicine News:Health News:Susan G. Komen for the Cure and RE/MAX Launch Home for the Cure™ 2Health News:Susan G. Komen for the Cure and RE/MAX Launch Home for the Cure™ 3Health News:Susan G. Komen for the Cure and RE/MAX Launch Home for the Cure™ 4Health News:St. Gregory Centers, Inc. Announces Integrating Mayo Clinic Health Wellness Program 2Health News:Chlordecone exposure and risk of prostate cancer 2Health News:OHSU School of Dentistry team examines how to rapily assess children's tooth decay risk 2Health News:Pro Ana Versus Pro Recovery Sites: New Study by Johns Hopkins and Stanford University raises concerns. 2Health News:Pro Ana Versus Pro Recovery Sites: New Study by Johns Hopkins and Stanford University raises concerns. 3
Microsurgical straight forceps made of titanium has straight shafts with smooth working surface. TCI working parts 6 mm from tips with round handle, diam. 6 mm, overall length 116 mm....
Curved tying forceps made of titanium has curved shafts with 6 mm V-grove tying platforms, width of shafts 0,5 mm, TCI platforms, flat handle, width 10 mm, overall length 103 mm....
Curved tying spring forceps made of titanium, delicate smooth jaws, length 10 mm, TCI jaws with round handle, diam. 8 mm and overall length 115 mm....
Thornton titanium curved suture tying forceps, 4"....
Medicine Products: